Skip to main content

Table 1 Coverage and timeliness of vaccines in the South African EPI program.

From: Vaccination coverage and timeliness in three South African areas: a prospective study

  Site Coverage
(end of follow-up)
Timely vaccination Given too early Given too late Not given
(at end of follow-up)
Polio 0 Paarl 99 (96-100) 99 (96-100) 0 (0-0) 0 (0-0) 1 (0-4)
  Umlazi 100 (98-100) 99 (97-100) 0 (0-0) 1 (0-1) 0 (0-2)
  Rietvlei 99 (96-100) 94 (91-97) 0 (0-0) 4 (3-6) 1 (0-4)
  Total 100 (99-100) 97 (96-98) 0 (0-0) 3 (2-3) 0 (0-1)
BCG vaccine Paarl 99 (97-100) 99 (97-100) 0 (0-0) 0 (0-0) 1 (0-3)
  Umlazi 100 (98-100) 100 (98-100) 0 (0-0) 0 (0-0) 0 (0-2)
  Rietvlei 99 (97-100) 99 (97-100) 0 (0-0) 0 (0-0) 1 (0-3)
  Total 99 (98-100) 99 (98-100) 0 (0-0) 0 (0-0) 1 (0-2)
Polio 1 Paarl 100 (98-100) 92 (90-93) 1 (0-2) 7 (5-8) 0 (0-2)
  Umlazi 99 (98-100) 88 (86-89) 1 (0-3) 10 (8-12) 1 (0-2)
  Rietvlei 96 (92-98) 72 (67-75) 1 (0-4) 22 (19-25) 4 (2-8)
  Total 99 (98-99) 85 (84-87) 1 (1-2) 12 (11-14) 1 (1-2)
DPT1+Hib+HBV Paarl 100 (98-100) 93 (90-94) 0 (0-2) 6 (4-8) 0 (0-2)
  Umlazi 99 (98-100) 88 (86-89) 1 (1-3) 10 (8-12) 1 (0-2)
  Rietvlei 97 (95-99) 77 (73-79) 2 (1-4) 19 (16-21) 3 (1-5)
  Total 99 (98-100) 87 (85-88) 1 (1-2) 11 (10-12) 1 (0-2)
Polio 2 Paarl 99 (97-100) 94 (92-94) 1 (0-2) 4 (3-5) 1 (0-3)
  Umlazi 98 (96-99) 90 (87-91) 0 (0-2) 8 (6-9) 2 (1-4)
  Rietvlei 87 (82-91) 72 (67-75) 1 (0-3) 14 (12-14) 13 (9-18)
  Total 96 (94-97) 87 (85-88) 1 (0-1) 8 (7-9) 4 (3-6)
DPT2+Hib+HBV Paarl 99 (97-100) 95 (93-95) 0 (0-2) 3 (2-4) 1 (0-3)
  Umlazi 98 (96-99) 90 (88-91) 0 (0-2) 7 (6-8) 2 (1-4)
  Rietvlei 92 (88-95) 80 (75-82) 0 (0-3) 12 (10-13) 8 (5-12)
  Total 97 (96-98) 90 (88-91) 0 (0-1) 7 (6-8) 3 (2-4)
Polio 3 Paarl 94 (91-96) 93 (91-94) 1 (0-3) 0 (0-0) 6 (4-9)
  Umlazi 98 (96-99) 87 (83-88) 0 (0-2) 11 (9-13) 2 (1-4)
  Rietvlei 69 (62-75) 64 (57-71) 0 (0-0) 5 (4-5) 31 (25-38)
  Total 87 (85-89) 84 (82-86) 0 (0-1) 2 (2-3) 13 (11-15)
DPT3+Hib+HBV Paarl 94 (91-96) 92 (90-93) 1 (0-3) 0 (0-0) 6 (4-9)
  Umlazi 90 (87-93) 86 (83-88) 0 (0-2) 4 (3-4) 10 (7-13)
  Rietvlei 74 (68-80) 70 (64-73) 0 (0-3) 4 (4-4) 26 (20-32)
  Total 88 (86-90) 85 (83-86) 1 (0-1) 3 (3-3) 12 (10-14)
  1. Coverage at end of follow-up and the proportion receiving the vaccinations within the recommended time periods (timely vaccination) are presented with 95% confidence intervals. Similarly, untimely vaccination are categorised into vaccines given earlier or later than recommended. Rates given for each of the three sites and in total
  2. * The pentavalent vaccine (DPT1+Hib+HBV) protects against diphtheria, pertussis, tetanus, Haemophilus influenzae type b and hepatitis B
\